从 Talaromyces cellulolyticus 真菌中分离出四种新的酚类化合物

IF 1.3 4区 生物学 Q4 CHEMISTRY, MEDICINAL
Zhijun Song , Dawei Chen , Jungui Dai
{"title":"从 Talaromyces cellulolyticus 真菌中分离出四种新的酚类化合物","authors":"Zhijun Song ,&nbsp;Dawei Chen ,&nbsp;Jungui Dai","doi":"10.1016/j.phytol.2024.09.003","DOIUrl":null,"url":null,"abstract":"<div><div>Four new phenolic compounds talarocelic A–D (<strong>1</strong>–<strong>4</strong>), together with four known compounds (<strong>5</strong>–<strong>8</strong>) were isolated from the fungus <em>Talaromyces cellulolyticus</em> CBS136886. Their chemical structures were elucidated through extensive spectroscopic data analysis such as HR-ESI-MS, UV, IR, and 1D- and 2D-NMR. Biological assay results revealed that compound <strong>6</strong> displayed potent protein tyrosine phosphatase 1B and <em>α</em>-glucosidase inhibitory activities with inhibition rates of 91.7 % and 59.6 %, respectively, at 10 μM. In addition, compound <strong>6</strong> showed moderate anti-inflammatory activity with 56.4 % inhibition at 10 μM and anti-bacterial activity against <em>Staphylococcus aureus</em> with a minimum inhibitory concentration of 12.5 μg/mL. This work not only reveals that <em>T. cellulolyticus</em> is rich in phenolic compounds but also provides access to diverse bioactive lead compounds for drug discovery.</div></div>","PeriodicalId":20408,"journal":{"name":"Phytochemistry Letters","volume":"64 ","pages":"Pages 19-24"},"PeriodicalIF":1.3000,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Isolation of four new phenolic compounds from the fungus Talaromyces cellulolyticus\",\"authors\":\"Zhijun Song ,&nbsp;Dawei Chen ,&nbsp;Jungui Dai\",\"doi\":\"10.1016/j.phytol.2024.09.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Four new phenolic compounds talarocelic A–D (<strong>1</strong>–<strong>4</strong>), together with four known compounds (<strong>5</strong>–<strong>8</strong>) were isolated from the fungus <em>Talaromyces cellulolyticus</em> CBS136886. Their chemical structures were elucidated through extensive spectroscopic data analysis such as HR-ESI-MS, UV, IR, and 1D- and 2D-NMR. Biological assay results revealed that compound <strong>6</strong> displayed potent protein tyrosine phosphatase 1B and <em>α</em>-glucosidase inhibitory activities with inhibition rates of 91.7 % and 59.6 %, respectively, at 10 μM. In addition, compound <strong>6</strong> showed moderate anti-inflammatory activity with 56.4 % inhibition at 10 μM and anti-bacterial activity against <em>Staphylococcus aureus</em> with a minimum inhibitory concentration of 12.5 μg/mL. This work not only reveals that <em>T. cellulolyticus</em> is rich in phenolic compounds but also provides access to diverse bioactive lead compounds for drug discovery.</div></div>\",\"PeriodicalId\":20408,\"journal\":{\"name\":\"Phytochemistry Letters\",\"volume\":\"64 \",\"pages\":\"Pages 19-24\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2024-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Phytochemistry Letters\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1874390024001332\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytochemistry Letters","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1874390024001332","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

从真菌 Talaromyces cellulolyticus CBS136886 中分离出了四种新的酚类化合物 Talarocelic A-D(1-4)和四种已知化合物(5-8)。通过大量光谱数据分析,如 HR-ESI-MS、UV、IR、1D-和 2D-NMR 等,阐明了这些化合物的化学结构。生物检测结果表明,化合物 6 具有很强的蛋白酪氨酸磷酸酶 1B 和 α-葡萄糖苷酶抑制活性,在 10 μM 时的抑制率分别为 91.7% 和 59.6%。此外,化合物 6 显示出中等程度的抗炎活性,在 10 μM 时抑制率为 56.4%,对金黄色葡萄球菌的抗菌活性最低抑制浓度为 12.5 μg/mL。这项工作不仅揭示了纤维溶解蘑菇富含酚类化合物,还为药物发现提供了多种生物活性先导化合物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Isolation of four new phenolic compounds from the fungus Talaromyces cellulolyticus
Four new phenolic compounds talarocelic A–D (14), together with four known compounds (58) were isolated from the fungus Talaromyces cellulolyticus CBS136886. Their chemical structures were elucidated through extensive spectroscopic data analysis such as HR-ESI-MS, UV, IR, and 1D- and 2D-NMR. Biological assay results revealed that compound 6 displayed potent protein tyrosine phosphatase 1B and α-glucosidase inhibitory activities with inhibition rates of 91.7 % and 59.6 %, respectively, at 10 μM. In addition, compound 6 showed moderate anti-inflammatory activity with 56.4 % inhibition at 10 μM and anti-bacterial activity against Staphylococcus aureus with a minimum inhibitory concentration of 12.5 μg/mL. This work not only reveals that T. cellulolyticus is rich in phenolic compounds but also provides access to diverse bioactive lead compounds for drug discovery.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Phytochemistry Letters
Phytochemistry Letters 生物-生化与分子生物学
CiteScore
3.00
自引率
11.80%
发文量
190
审稿时长
34 days
期刊介绍: Phytochemistry Letters invites rapid communications on all aspects of natural product research including: • Structural elucidation of natural products • Analytical evaluation of herbal medicines • Clinical efficacy, safety and pharmacovigilance of herbal medicines • Natural product biosynthesis • Natural product synthesis and chemical modification • Natural product metabolism • Chemical ecology • Biotechnology • Bioassay-guided isolation • Pharmacognosy • Pharmacology of natural products • Metabolomics • Ethnobotany and traditional usage • Genetics of natural products Manuscripts that detail the isolation of just one new compound are not substantial enough to be sent out of review and are out of scope. Furthermore, where pharmacology has been performed on one new compound to increase the amount of novel data, the pharmacology must be substantial and/or related to the medicinal use of the producing organism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信